Minnetronix Announces Appointment of Elissa Lindsoe as Chief Financial Officer
Minnetronix, Inc., a leading medical technology company, today announced the appointment of Elissa Lindsoe as Chief Financial Officer (CFO). A seasoned financial leader, Lindsoe brings more than 25 years of experience and a proven track record of successful financial management and direction to the company.
Prior to joining Minnetronix, Lindsoe served as CFO of MOCON, a Minnesota based global manufacturing company, where she was a key contributor to the successful sale of the organization to AMETEK. Following the acquisition, Lindsoe served as an independent consultant supporting MOCON’s transition into AMETEK. Her experience also includes CFO roles for private and publicly traded companies including Galil Medical, Urologix and Identix. Lindsoe holds a Bachelor of Accounting degree from the University of Minnesota-Duluth.
“We look forward to welcoming Elissa to the Minnetronix team at such an important and dynamic time in our company’s history. She is a proven and accomplished leader who will play an instrumental role in providing financial vision, strategy and leadership as we expand and grow our position in the market,” said Jeremy Maniak, President of Minnetronix.
“Minnetronix is a unique company with an equally unique opportunity to accelerate its impact on the medical device market. I am looking forward to being part of a company with such a bright future and a compelling mission.” Lindsoe said.
Minnetronix is a medical technology and innovation company with deep expertise in electronic and electromechanical devices. Founded in 1996, the company creates new technologies and therapies that solve unmet clinical and business needs for patients and medical device companies. Minnetronix is FDA Registered and ISO 13485 Certified. www.minnetronix.com.